Radiation therapy-related toxicity (including pneumonitis and fibrosis)

Hematology/Oncology Clinics of North America

Volumn 24, Issue 3, 2010, Pages 625-642

  Chopra, Rahul R ^a   Bogart, Jeffrey A ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Corticosteroids; Endarteritis; Fibrosis; Inflammation; Radiation therapy; Toxicity

Indexed keywords

ALPHA TOCOPHEROL; AMIFOSTINE; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIEMETIC AGENT; BENZOCAINE; CAPTOPRIL; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; EAR DROPS; HEPARIN; KERATINOCYTE GROWTH FACTOR; ORATECT; PENTOXIFYLLINE; PILOCARPINE; PLACEBO; PREDNISONE; RADIOPROTECTIVE AGENT; STEROID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; UREA PEROXIDE; WARFARIN;

ALOPECIA; BONE PAIN; BRAIN EDEMA; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; CERUMEN IMPACTION; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSPHAGIA; ERYTHEMA; FATIGUE; FIBROSIS; HEAD AND NECK DISEASE; HEADACHE; HEMOPTYSIS; HUMAN; HYPERTENSION; LEUKOENCEPHALOPATHY; LUNG FIBROSIS; LUNG INJURY; LUNG TOXICITY; MIDDLE EAR DISEASE; MUCOSA INFLAMMATION; NAUSEA; NEUROENDOCRINE DISEASE; NEUROTOXICITY; NONHUMAN; PHARYNX DISEASE; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION INJURY; RADIATION MYELOPATHY; RADIATION NECROSIS; RADIATION PNEUMONIA; REVIEW; RIB FRACTURE; SEROUS OTITIS MEDIA; SKIN FIBROSIS; SKIN TOXICITY; SOFT TISSUE DISEASE; THERAPY EFFECT; XEROSTOMIA;

EID: 77952905244     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2010.03.009     Document Type: Review

References (71)

1. Khan F.M. Interactions of ionizing radiation. The Physics of radiation therapy 2003, 59-61. Lippincott Williams & Wilkins, Philadelphia.
2. Hall E.J., Giaccia E.J. Physics and chemistry of radiation absorption. Radiobiology for the radiologist 2006, 5-14. Lippincott Williams & Wilkins, Philadelphia.
3. Hall E.J., Giaccia E.J. Clinical response of normal tissues. Radiobiology for the radiologist 2006, 327-344. Lippincott Williams & Wilkins, Philadelphia.
4. Goodman M., Hilderly L.J., Purl S. Integumentary and mucous membrane alterations. Cancer nursing principles and practice 1997, 768-822. Jones and Bartlett, Boston (MA). 4th edition. S.L. Groenwald, M. Goodman, C.H. Yarbro (Eds.).
5. Wood G., Casey L., Trotti A. Skin changes. Radiation toxicity: a practical guide 2006, 170-181. Springer Science, New York. W. Small, G.E. Woloschak (Eds.).
6. Lefaix J.L., Delanian S., Vozenin M.C., et al. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 1999, 43(4):839-847.
7. Delanian S., Porcher R., Balla-Mekias S., et al. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003, 21(13):2545-2550.
8. Delanian S., Porcher R., Rudant J., et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 2005, 23(34):8570-8579.
9. Feldmeier J.J., Heimbach R.D., Davolt D.A., et al. Hyperbaric oxygen as an adjunctive treatment for delayed radiation injury of the chest wall: a retrospective review of twenty-three cases. Undersea Hyperb Med 1995, 22(4):383-393.
10. Chen Y., Williams J., Ding I., et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002, 12(1 Suppl 1):26-33.
11. Monson J.M., Stark P., Reilly J.J. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998, 82(5):842-850.
12. Marks L.B., Yu X., Vujaskovic Z., et al. Radiation-induced lung injury. Semin Radiat Oncol 2003, 13(3):333-345.
13. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 1998, 41(5):1029-1035.
14. Smith L.M., Mendenhall N.P., Cicale M.J., et al. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys 1989, 16(1):79-84.
15. Anscher M.S., Marks L.B., Shafman T.D., et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 56(4):988-995.
16. Arbetter K.R., Prakash U.B., Tazelaar H.D., et al. Radiation-induced pneumonitis in the " nonirradiated" lung. Mayo Clin Proc 1999, 74(1):27-36.
17. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer-a systematic review. Radiother Oncol 2004, 71(2):127-138.
18. Brady L.W., Germon P.A., Cander L. The effects of radiation therapy on pulmonary function in carcinoma in the Lung. Radiology 1965, 85:130-134.
19. Constine L.S., Milano M.T., Friedman D., et al. Late effects of cancer treatment on normal tissues. Perez and Brady's principles and practice of radiation oncology 2007, 320-355. Lippincott Williams & Wilkins, Philadelphia. 5th edition. E.C. Halperin, C.A. Perez, L.W. Brady (Eds.).
20. Bradley J., Movsas B. Radiation pneumonitis and esophagitis in thoracic irradiation. Radiation toxicity: a practical guide 2006, 42-53. Springer Science, New York. W. Small, G.E. Woloschak (Eds.).
21. Komaki R., Lee J.S., Milas L., et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 2004, 58(5):1369-1377.
22. Ward W.F., Molteni A., Tsao C.H. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 1989, 117(2):342-350.
23. Anscher M.S., Thrasher B., Zgonjanin L., et al. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2008, 71(3):829-837.
24. Kelly J.F., Delclos M.E., Morice R.C., et al. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M.D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 2000, 48(3):697-702.
25. Ozkok S., Karakoyun-Celik O., Goksel T., et al. High dose rate endobronchial brachytherapy in the management of lung cancer: Response and toxicity evaluation in 158 patients. Lung Cancer 2008, 62(3):326-333.
26. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
27. Jereczek-Fossa B.A., Zarowski A., Milani F., et al. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003, 29(5):417-430.
28. Freeman J.E., Johnston P.G., Voke J.M. Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J 1973, 4:523.
29. Uzal D., Ozyar E., Hayran M., et al. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Radiother Oncol 1998, 48:29.
30. Schultheiss T., Kun L., Ang K., et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995, 31:1093.
31. Jones A.M. Transient radiation myelopathy. Br J Radiol 1964, 37(727):744.
32. Burger P.C., Mahley M.S., Dudka L., et al. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 1979, 44(4):1256-1272.
33. Henry R.G., Vigneron D.B., Fischbein N.J., et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000, 21(2):357-366.
34. Glantz M.J., Burger P.C., Friedman A.H., et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994, 44(11):2020-2027.
35. Chuba P.J., Aronin P., Bhambhani K., et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 1997, 80(10):2005-2012.
36. Price R.A., Jamieson P.A. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975, 35(2):306-318.
37. Frytak S., Shaw J.N., O'Neill B.P., et al. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 1989, 12(1):27.
38. Mulhern R.K., Khan R.B., Kaplan S., et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004, 22(23):4795-4803.
39. Shaw E.G., Rosdhal R., D'Agostino R.B., et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006, 24(9):1415-1420.
40. Le Bars P.L., Katz M.M., Berman N. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997, 278:1327-1332.
41. Schultheiss T.E., Higgins E.M., El-Mahdi A.M. The latent period in clinical radiation myelopathy. Int J Radiat Oncol Biol Phys 1984, 10(7):1109-1115.
42. Wang P.Y., Shen W.C., Jan J.S. Serial MRI changes in radiation myelopathy. Neuroradiology 1995, 37(5):374-377.
43. Luk K.H., Baker D.G., Fellows C.F. Hyperbaric oxygen after radiation and its effect on the production of radiation myelitis. Int J Radiat Oncol Biol Phys 1978, 4(5-6):457-459.
44. Andratschke N.H., Nieder C., Price R.E., et al. Potential role of growth factors in diminishing radiation therapy neural tissue injury. Semin Oncol 2005, 32(2 Suppl 3):S67-S70.
45. Constine L.S., Woolf P.D., Cann D., et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993, 328(2):87-94.
46. Blanco A.I., Chao C. Management of radiation-induced head and neck injury. Radiation toxicity: a practical guide 2006, 23-39. Springer Science, New York. W. Small, G.E. Woloschak (Eds.).
47. Büntzel J., Küttner K., Fröhlich D., et al. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 1998, 9(5):505-509.
48. Wasserman T.H., Brizel D.M., Henke M., et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 2005, 63(4):985-990.
49. Fisher J., Scott C., Scarantino C.W. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. Int J Radiat Oncol Biol Phys 2003, 56(3):832-836.
50. Reuther T., T Schuster T., Mende U. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003, 32:289-295.
51. Wong J.K., Wood R.E., McLean M. Conservative management of osteoradionecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84(1):16-21.
52. Shaha A.R., Cordeiro P.G., Hidalgo D.A., et al. Resection and immediate microvascular reconstruction in the management of osteoradionecrosis of the mandible. Head Neck 1997, 19(5):406-411.
53. Marx R.E., Ames J.R. The use of hyperbaric oxygen therapy in bony reconstruction of the irradiated and tissue-deficient patient. J Oral Maxillofac Surg 1982, 40(7):412-420.
54. Tibbles P.M., Edelsberg J.S. Hyperbaric Oxygen Therapy. N Engl J Med 1996, 334(25):1642-1648.
55. Hart G.B., Mainous E.G. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer 1976, 37:2580-2585.
56. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002, 53:23-28.
57. Lee H.J., Zelefsky M.J., Kraus D.H., et al. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys 1997, 38(5):995-1000.
58. Verdonck-de Leeuw I.M., Keus R.B., Hilgers F.J., et al. Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance. Int J Radiat Oncol Biol Phys 1999, 44(5):1071-1078.
59. Anscher M.S., Peters W.P., Reisenbichler H., et al. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993, 328(22):1592-1598.
60. Babb R.R. Radiation proctitis: a review. Am J Gastroenterol 1996, 91(7):1309-1311.
61. O'Brien P.C., Hamilton C.S., Denham J.W., et al. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58(1):75-80.
62. Chrouser K.L., Leibovich B.C., Sweat S.D., et al. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol 2005, 173(6):1953-1957.
63. Gilinsky N.H., Burns D.G., Barbezat G.O., et al. The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. QJM 1983, 52(205):40-53. Winter.
64. Kochhar R., Patel F., Dhar A., et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci 1991, 36(1):103-107.
65. Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 53(1):91-98.
66. Corman J.M., McClure D., Pritchett R., et al. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003, 169(6):2200-2202.
67. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994, 12(3):447-453.
68. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001, 49(4):1023-1028.
69. Orzan F., Brusca A., Gaita F., et al. Associated cardiac lesions in patients with radiation-induced complete heart block. Int J Cardiol 1993, 39(2):151-156.
70. Hull M.C., Morris C.G., Pepine C.J., et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290(21):2831-2837.
71. Swerdlow A.J., Higgins C.D., Smith P., et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007, 99(3):206-214.